FSD Pharma Inc. (HUGE)
NASDAQ: HUGE · IEX Real-Time Price · USD
0.700
-0.010 (-1.41%)
Mar 28, 2024, 2:17 PM EDT - Market open

FSD Pharma Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Year 202220212020201920182017
Revenue
000000.03
Gross Profit
000000.03
Selling, General & Admin
14.4515.9310.068.4118.740.36
Research & Development
6.916.337.83000
Other Operating Expenses
6.0711.4912.814.0814.123.19
Operating Expenses
27.4333.7430.6922.4832.863.55
Operating Income
-27.43-33.74-30.69-22.48-32.86-3.52
Interest Expense / Income
0.050.070.240.1600
Other Expense / Income
-3.871.470.8716.49-10.15-
Pretax Income
-23.61-35.29-31.8-39.13-22.71-3.52
Net Income
-23.61-35.29-31.8-39.13-22.71-3.52
Shares Outstanding (Basic)
393512762
Shares Outstanding (Diluted)
39351276-
Shares Change
10.84%190.15%70.69%19.49%169.63%-
EPS (Basic)
-0.61-1.01-2.64-5.55-3.85-1.61
EPS (Diluted)
-0.61-1.01-2.64-5.55-3.85-
Free Cash Flow
-28.7-21.25-19.13-14.01-22.52-7.8
Free Cash Flow Per Share
-0.74-0.61-1.59-1.99-3.81-3.56
Gross Margin
-----100.00%
Operating Margin
------13585.61%
Profit Margin
------13585.61%
Free Cash Flow Margin
------30078.80%
EBITDA
-19.02-31.17-27.66-37.03-22.53-3.52
EBITDA Margin
------13585.61%
Depreciation & Amortization
4.534.053.91.940.180
EBIT
-23.56-35.22-31.56-38.97-22.71-3.52
EBIT Margin
------13585.61%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).